-
-
-
-
-
-
-
Calidi Biotherapeutics (CLDI) Misses Q1 EPS by 18c
-
-
-
-
-
-
-
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
-
1,220,222 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

